Savient Pharmaceuticals is a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical products that target unmet medical needs in rheumatology and other specialty niche medical markets. Our focus is on our novel biologic product candidate, KRYSTEXXA (pegloticase) for intravenous infusion.